Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Yukako Ogi
Idarucizumab for Emergency Reversal of Anticoagulant Effects of Dabigatran: Interim Results of a Japanese Post-Marketing Surveillance Study
Cardiology and Therapy
Related publications
Idarucizumab for Urgent Reversal of Dabigatran for Heart Transplant: A Case Report
American Journal of Hematology
Hematology
Idarucizumab for the Reversal of Dabigatran in Patients Undergoing Heart Transplantation
European Journal of Heart Failure
Cardiovascular Medicine
Cardiology
Immediate Reversal of Dabigatran by Idarucizumab Prior to Laboratory and Imaging Results in Acute Stroke
Frontiers in Neurology
Neurology
Successful Intravenous Thrombolysis for Ischemic Stroke After Reversal of Dabigatran Anticoagulation With Idarucizumab: A Case Report
Journal of Medical Case Reports
Medicine
Treatment of Comorbid Anxiety and Depression With Escitalopram: Results of a Post-Marketing Surveillance Study
Pharmacopsychiatry
Medicine
Psychiatry
Mental Health
Pharmacology
Adverse Clinical Outcomes After Dabigatran Reversal With Idarucizumab to Facilitate Acute Stroke Thrombolysis
Journal of Neurology
Neurology
Safety and Effectiveness of Istradefylline in Patients With Parkinson’s Disease: Interim Analysis of a Post-Marketing Surveillance Study in Japan
Expert Opinion on Pharmacotherapy
Medicine
Pharmacology
Real-World Evidence for the Safety of Ipragliflozin in Elderly Japanese Patients With Type 2 Diabetes Mellitus (STELLA-ELDER): Final Results of a Post-Marketing Surveillance Study
Expert Opinion on Pharmacotherapy
Medicine
Pharmacology
Post-Marketing Surveillance
